Japanese drug major Mitsubishi Tanabe Pharma Corporation has announced that it will launch Kremezin Tablets 500mg (spherical cabonaceouse adsorbent), a new formula of the chronic renal failure drug, on Tuesday, January 16. 11 January 2018
Washington, USA-based PharmaIN Corporation and Japan’s Shionogi have agreed terms for a drug development collaboration based around the former’s peptide engineering technologies. 11 January 2018
Zinplava (bezlotoxumab), the first European Commission-licensed non-antibiotic option indicated to prevent Clostridium difficile infection (CDI) recurrence in high-risk adults, has been launched in the UK. 10 January 2018
The European Investment Bank (EIB) is providing a loan of 40 million ($47.7 million) to Indivumed, a physician-led, global oncology company with headquarters in Germany. 10 January 2018
A US court has asked Canada-based Valeant Pharmaceuticals and Bill Ackman's hedge fund Pershing Square to appear for a hearing, set for January 16, to discuss the proposed settlement in an insider trading lawsuit. 3 January 2018
Spanish drugmaker PharmaMar has announced a commercialization and distribution license agreement with Megapharm for the marine-derived anticancer drug Aplidin (plitidepsin) in Israel and the territory known as the Palestinian Authority. 2 January 2018
Canada based ImmunoPrecise has signed a binding letter of intent with privately-held German firm Preclinics GmbH, whereby the company has agreed to acquire all of the issued and outstanding shares of Preclinics. 29 December 2017
Eisai announced today that its in-house discovered and developed anticancer agent lenvatinib mesylate (product names: Lenvima and Kisplyx) for use in the treatment of hepatocellular carcinoma (HCC), which was submitted for approval in China in October 2017, has been designated for priority review and approval by the China Food and Drug Administration (CFDA). 27 December 2017
A US district judge has overturned a $150 million verdict against US pharma firm AbbVie that was the first to result from lawsuits claiming the company fraudulently misrepresented the risks of its AndroGel testosterone replacement drug, according to media reports including Seeking Alpha. 26 December 2017
The US Food and Drug Administration has approved Roche’s Perjeta (pertuzumab), in combination with Herceptin (trastuzumab) and chemotherapy as adjuvant treatment for certain breast cancer patients. 21 December 2017
Belgian drug discovery firm Confo Therapeutics is to collaborate with Roche to discover novel small molecules and bring them through to commercialization. 19 December 2017
Privately-held German company Boehringer Ingelheim is to team up with Swiss pharma giant Roche in the discovery and development of orally available novel Locked Nucleic Acid (LNA) oligonucleotides for the treatment of inflammatory bowel diseases (IBDs). 19 December 2017
The US Food and Drug Administration (FDA) has published draft guidance on how it will issue and use information requests (IRs) and discipline review letters (DRLs) during the review of an original abbreviated new drug application under the Generic Drug User Fee Amendments of 2017. 19 December 2017
Japan’s largest drugmaker Takeda Pharmaceutical today announced the termination of co-promotion of the oral JAK inhibitor rheumatoid arthritis product Xeljanz (tofacitinib citrate) tablets 5mg as of March 31, 2018. 18 December 2017
Spectrum Pharmaceuticals has replaced its CEO Rajesh Shrotriya with Joseph Turgeon, the firm’s current chief operating officer, who will also join the board. 18 December 2017
Swiss pharma giant Novartis announced today that Bruno Strigini, chief executive of Novartis Oncology has decided to retire from Novartis and the industry for personal reasons. 15 December 2017
The deadline to update or certify companies’ drug listings with the US Food and Drug Administration, December 31, 2017, is fast approaching, the agency is warning the pharmaceutical industry. 15 December 2017
Indianapolis, USA-based Eli Lilly has announced 2018 financial guidance of low-single-digit revenue growth, sending the firm’s share price up over a dollar or 1.5% in morning trading. 13 December 2017
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Gan & Lee Pharmaceuticals as reported that its three investigational drugs - GZR18, GZR4, and GZR101 - achieved positive results in Phase II diabetes trials. 17 October 2024
A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget, due on October 30. 17 October 2024
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza Vaccine) to include data from a new safety study involving pregnant women. 17 October 2024
Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma giant Novartis for a small molecule anti-tumor asset. 17 October 2024
Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), an innovative siderophore cephalosporin. 17 October 2024
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024